PA
CDMO

Profund Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Profund Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,667
Closed -$255K – 1123
2024
Q4 		$255K Sell
20,667
-2,280
-10% -$26.1K 0.01% 860
2024
Q3 		$261K Sell
22,947
-11,018
-32% -$111K 0.01% 884
2024
Q2 		$243K Sell
33,965
-47,002
-58% -$360K 0.01% 856
2024
Q1 		$542K Buy
80,967
+19,315
+31% +$133K 0.02% 544
2023
Q4 		$401K Buy
61,652
+26,309
+74% +$170K 0.02% 629
2023
Q3 		$334K Sell
35,343
-4,701
-12% -$56.6K 0.02% 613
2023
Q2 		$559K Buy
40,044
+4,069
+11% +$69.4K 0.03% 478
2023
Q1 		$675K Buy
+35,975
New +$591K 0.04% 411
2015
Q3 		– Sell
-1,629
Closed -$15K – 1384
2015
Q2 		$15K Buy
1,629
+154
+10% +$1.48K ﹤0.01% 1470
2015
Q1 		$14K Buy
+1,475
New +$14.2K ﹤0.01% 1526
2014
Q3 		– Sell
-2,775
Closed -$37K – 1456
2014
Q2 		$37K Sell
2,775
-139
-5% -$1.75K ﹤0.01% 1546
2014
Q1 		$39K Buy
2,914
+1,141
+64% +$15K ﹤0.01% 1582
2013
Q4 		$17K Buy
1,773
+316
+22% +$2.97K ﹤0.01% 1692
2013
Q3 		$14K Buy
+1,457
New +$14.5K ﹤0.01% 1644

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Profund Advisors's CDMO Position: Q1 2025 in Review

Profund Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 20,667 shares — an estimated $255K sold.

Profund Advisors first reported a position in CDMO in Q3 2013 and held it in 14 quarters. The position peaked at $675K in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Profund Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Profund Advisors sold 20,667 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $255K.
  • Profund Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2013 and held it in 14 quarters.
  • Profund Advisors's Avid Bioservices, Inc. Common Stock position peaked at $675K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Profund Advisors's 13F filing for Q1 2025, filed 8 May 2025.